Live tape
Top 8, mentions 7d10,673GOOGL2,039 mentions▲ +0.04SNDK1,513 mentions▲ +0.11SPCX1,491 mentions▲ +0.08NBIS1,416 mentions▲ +0.09HTZ1,230 mentions▲ +0.10NVDA1,172 mentions▲ +0.08META984 mentions▲ +0.03MSFT828 mentions▲ +0.06

Equity · Healthcare

KYMR

Kymera Therapeutics, Inc. · NasdaqGM

$116 +1.75% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 40 sessions
$120 $60 20 May 17 Jul

The line runs $80.77 on 20 May through $116 on 17 July, on a scale from $60 to $120. Days the market did not trade hold the previous close, flat.

The chart above plots the price of KYMR over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 40 sessions over that window: $80.77 on 20 May 2026 through $116 on 17 July 2026.

Market cap $9.6B
52-week range $38 – $119.06
Avg volume 311.6K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

KYMR insider trades

SEC Form 4 · last 90 days · newest reported trade 29 Jun 2026
Open-market buys 0
Open-market sells 9
Net sold $369.22M
Non-trade filings 1
Date Insider Type Shares Value
29 Jun 2026 Booth Bruce Director Sell 153,300 $16.56M
26 Jun 2026 Booth Bruce Director Sell 467,878 $51.60M
26 Jun 2026 BVF PARTNERS L P/IL Director Sell 1,630,658 $173.67M
25 Jun 2026 Booth Bruce Director Sell 548,321 $65.12M
24 Jun 2026 Booth Bruce Director Sell 134,720 $13.54M
23 Jun 2026 Booth Bruce Director Sell 1,408 $141K
22 Jun 2026 Booth Bruce Director Sell 278,128 $27.57M
18 Jun 2026 Booth Bruce Director Sell 115,056 $10.47M
17 Jun 2026 Booth Bruce Director Sell 116,812 $10.55M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
17 Jun 2026 Booth Bruce Director Option exercise 11,741 $235K

KYMR reported financials

SEC EDGAR XBRL

KYMR reported revenue of $39.2M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$311.4M.

Figure Reported Period
Revenue $39.2M 31 Dec 2025 fiscal year
Net income −$311.4M 31 Dec 2025 fiscal year
Diluted EPS −$3.69 31 Dec 2025 fiscal year
Total assets $1.6B 30 Jun 2026 at period end
Total equity $1.5B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

KYMR earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.62 $65M
31 Mar 2026 Q1 2026 $-0.71 $34M
31 Dec 2025 FY 2025 $-3.69 $39M
30 Sep 2025 Q3 2025 $-0.94 $3M
30 Jun 2025 Q2 2025 $-0.95 $11M
31 Mar 2025 Q1 2025 $-0.82 $22M
31 Dec 2024 FY 2024 $-2.98 $47M
30 Sep 2024 Q3 2024 $-0.82 $4M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

KYMR institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a KYMR position for the quarter ended 30 Jun 2026 — a combined $1.1B; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) 8,657,242 $992.7M
Two Sigma Investments Added +44.8% shares 371,374 $42.6M
Marshall Wace New position 167,517 $19.2M
Citadel Advisors Held (±25%) −5.9% shares 111,555 $12.8M
Man Group Added +43.1% shares 19,085 $2.2M
Fisher Asset Management New position 12,732 $1.5M
AQR Capital Management Trimmed −40.2% shares 9,541 $1.1M
D. E. Shaw & Co. New position 2,800 $321K

Source: SEC EDGAR 13F filings

KYMR fails-to-deliver

SEC CNS data

On 31 Jul 2026, 1,482 shares of KYMR failed to deliver (about $159K) — the latest of 6 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
31 Jul 2026 1,482 $159K 0.002%
30 Jul 2026 76 $8K <0.001%
29 Jul 2026 40 $4K <0.001%
28 Jul 2026 45 $5K <0.001%
27 Jul 2026 178 $20K <0.001%
24 Jul 2026 234 $26K <0.001%
22 Jul 2026 80 $9K <0.001%
21 Jul 2026 101 $11K <0.001%
17 Jul 2026 62 $7K <0.001%
16 Jul 2026 42 $5K <0.001%
14 Jul 2026 311 $34K <0.001%
06 Jul 2026 9,216 $1.0M 0.011%

Source: SEC fails-to-deliver (CNS) data